Premier downgraded by Canaccord Genuity with a new price target
$PINC
Other Consumer Services
Consumer Discretionary
Canaccord Genuity downgraded Premier from Buy to Hold and set a new price target of $21.00 from $27.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/26/2024 | Buy → Hold | The Benchmark Company | |
| 5/8/2024 | $27.00 → $21.00 | Buy → Hold | Canaccord Genuity |
| 2/26/2024 | $22.50 | Market Perform | Leerink Partners |
| 1/3/2024 | $22.00 | Equal Weight | Barclays |
| 8/23/2023 | $44.00 → $25.00 | Overweight → Neutral | Piper Sandler |
| 5/3/2023 | $43.00 → $30.00 | Outperform → Neutral | Robert W. Baird |
| 5/2/2023 | Outperform → Mkt Perform | Raymond James | |
| 1/27/2023 | $38.00 | Underperform → Neutral | Credit Suisse |
Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that it has named David (Dave) Zito as President, Performance Services, effective December 6, 2024. Zito will oversee Premier's Performance Services segment, including the continued development and growth of the company's enterprise-wide, AI-enabled technology businesses and Premier's consulting practice. He will report to Michael J. Alkire, Premier's President and CEO. Zito is a seasoned healthcare executive, with expertise across provider networks, payer systems, life sciences and healthcare managed services. He served as the Chief Growth Officer for Guidehouse, where he was respon
144 - Premier, Inc. (0001577916) (Subject)
8-K - Premier, Inc. (0001577916) (Filer)
10-Q - Premier, Inc. (0001577916) (Filer)
Premier, Inc. (NASDAQ:PINC) today announced the nation's 15 Top Health Systems®. Premier's 15 Top Health Systems® annual study is the only study that includes a comprehensive analysis of the data supporting the nation's top performing health systems. Based on the data analyzed, it is estimated that if all health systems performed at the same level as this year's top performers, more than 171,000 additional lives could have been saved, and more than 336,000 additional patients could have been complication free for the 2025 report year. To create the list, an objective, quantitative analysis of publicly available data was conducted to identify the top health systems in the U.S. The primary
Integration delivers high-value datasets including chargemaster, laboratory results and EMR data to accelerate clinical and commercial insights PHILADELPHIA, May 13, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc. (NASDAQ:PINC) to HealthVerity Marketplace™, meaning life sciences organizations using HealthVerity Marketplace™ can now access Premier's high-quality, healthcare data to support research across the product lifecycle. HealthVerity Marketplace is the nat
Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the BofA Securities Healthcare Conference on Tuesday, May 13, 2025 at 9:20 a.m. PDT (12:20 p.m. EDT). A link to the live audio webcast, as well as a replay of this event, will be available in the Investors section of the company's website at https://investors.premierinc.com/overview/default.aspx under Events and Presentations. About Premier, Inc. Premier, Inc. (NASDAQ:PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Pl
4 - Premier, Inc. (0001577916) (Issuer)
4 - Premier, Inc. (0001577916) (Issuer)
4 - Premier, Inc. (0001577916) (Issuer)
SC 13G - Premier, Inc. (0001577916) (Subject)
SC 13G/A - Premier, Inc. (0001577916) (Subject)
SC 13G/A - Premier, Inc. (0001577916) (Subject)
Total net revenue of $261.4 million (total net revenue excluding Contigo Health* of $255.3 million) GAAP net income from continuing operations of $27.6 million, or $0.32 per fully diluted share Adjusted earnings per share excluding Contigo Health* of $0.46 Net cash provided by operating activities from continuing operations of $307.8 million and free cash flow* of $130.3 million for the first nine months of fiscal-year 2025 Increasing adjusted EBITDA and adjusted EPS guidance; reaffirming guidance midpoint for total net revenue excluding Contigo Health [1][2] Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today reported financial results
Premier, Inc. (NASDAQ:PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable no later than June 15, 2025, to stockholders of record as of the close of business on June 1, 2025. About Premier, Inc. Premier, Inc. (NASDAQ:PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare bett
Premier, Inc. (NASDAQ:PINC) today announced that it will release financial results for its fiscal 2025 third quarter on Tuesday, May 6, 2025, at approximately 6:30 a.m. ET. The company will also host a conference call at 8:00 a.m. ET to discuss its financial results. The live webcast and replay will be available in the Investors section of the company's website at Events & Presentations. The webcast should be accessed 10 minutes prior to the conference call start time. The replay of the event will be available for one year following the conclusion of the live broadcast. For those parties who do not have internet access, the conference call can be accessed by calling one of the below telep
The Benchmark Company downgraded Premier from Buy to Hold
Canaccord Genuity downgraded Premier from Buy to Hold and set a new price target of $21.00 from $27.00 previously
Leerink Partners initiated coverage of Premier with a rating of Market Perform and set a new price target of $22.50